Analyst consensus rating
Alamar Biosciences Analyst Rating: none
ALMR is rated none by 5 analysts with a $33.40 target. As of 2026-09-02.
Direct answer
Alamar Biosciences's consensus rating is none.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $33.40.
Forecast evidence checked September 2, 2026.
Get free Alamar Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $29.36
- Average price target
- $33.40
- High price target
- $35.00
- Low price target
- $31.00
- Low target gap
- +5.6%
- Target upside
- +13.8%
- High target gap
- +19.2%
- Target range width
- 13.6%
- Consensus rating
- none
- Analysts
- 5
- Evidence date
- September 2, 2026
- Valid through
- September 9, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Alamar Biosciences?
Alamar Biosciences has a verified none consensus. The same dataset has an average price target of $33.40.
How far are Alamar Biosciences's low and high targets from the recorded price?
The low target implies +5.6%, while the high target implies +19.2%.
How many analysts are included in Alamar Biosciences's consensus?
The verified consensus includes 5 analysts.
How is Alamar Biosciences's target upside or downside calculated?
The average target of $33.40 is divided by the recorded price of $29.36, then one is subtracted to produce +13.8%. This does not guarantee a future return.
When was Alamar Biosciences's analyst forecast verified?
The data was verified on 2026-09-02. The dataset is valid through 2026-09-09.